August 29th 2025
Patients with severe sickle cell disease experienced significant quality of life improvements after receiving exagamglogene autotemcel gene therapy.
Data on Delandistrogene Moxeparvovec Can Inform Future Gene Therapies
Despite Risk, Patients With SCD Hopeful About Gene Therapies